Change search criteria ↓

Search results

1 387 projects found matching your search criteria:

  1. 351. Directed screening and evaluation of novel bactericidal compounds active againsttubercle bacilli and Mycobacterium absce…

    Principal investigator: prof. Jarosław Dziadek

    Instytut Biologii Medycznej PAN

    Call: OPUS 25, Panel: NZ7

  2. 352. Compounds modulating function of telomeric proteins TRF1 and TRF2

    Principal investigator: prof. Maciej Wojciech Bagiński

    Politechnika Gdańska, Wydział Chemiczny

    Call: OPUS 25, Panel: NZ7

  3. 353. Unraveling protease activation in stimulated CAR-T cells to identify new biomarkers for assessing their clinical efficac…

    Principal investigator: dr hab. Małgorzata Firczuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 25, Panel: NZ7

  4. 354. Inactivation of intracellular Staphylococcus aureus and staphylococcal enterotoxins with photoactivated compounds in mod…

    Principal investigator: dr hab. Joanna Nakonieczna

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: OPUS 25, Panel: NZ7

  5. 355. Neuroprotective effect of SGLT2i: direct influence on amyloid-β related pathology

    Principal investigator: Agnieszka Pawlos

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ7

  6. 356. Curdlan-based biomaterial as a nanostructure carrier for controlled and targeted drug delivery in the treatment of deep …

    Principal investigator: dr Aleksandra Nurzyńska

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 22, Panel: NZ7

  7. 357. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 25, Panel: NZ7

  8. 358. Do metal nanoparticles affect the biosynthesis of bioactive plant metabolites? - studies on an in vitro culture model of…

    Principal investigator: dr hab. Agnieszka Szopa

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 25, Panel: NZ7

  9. 359. The cross-talk between 5-HTR2A and mGluR2 as a window for antidepressant effects of psilocybin.

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

    Call: OPUS 25, Panel: NZ7

  10. 360. Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

    Principal investigator: dr Natalia Eleonora Małek-Chudzik

    Politechnika Wrocławska

    Call: OPUS 25, Panel: NZ7

  11. 361. Amorphous Senolytics: A Breakthrough Approach in Senescence Modulation and Age-Related Disease Treatment

    Principal investigator: Szymon Sip

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: PRELUDIUM 22, Panel: NZ7

  12. 362. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  13. 363. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design…

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  14. 364. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ7

  15. 365. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr…

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: OPUS 25, Panel: NZ7

  16. 366. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen…

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polska Akademia Nauk

    Call: OPUS 25, Panel: NZ7

  17. 367. The Way to longevity - Effects of resveratrol or/and nanodiamonds on sirtuin activity in Acheta domesticus

    Principal investigator: Patrycja Joanna Ziętara-Krzyk

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Przyrodniczych

    Call: PRELUDIUM 22, Panel: NZ7

  18. 368. Are bisphenol S and F safe substitutes for bisphenol A in the face of environmental contamination with estrogenic mycoto…

    Principal investigator: Marta Justyna Kozieł

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ7

  19. 369. Assessment of twin screw extrusion potential as a continuous and scalable method of mechanochemical synthesis of active …

    Principal investigator: Anna Magdalena Gołkowska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

    Call: PRELUDIUM 22, Panel: NZ7

  20. 370. Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

    Principal investigator: Alex Jun Matsuda

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: PRELUDIUM 22, Panel: NZ7

  21. 371. The Role of the Mitochondrial Unfolded Protein Response (UPRmt) in Endothelial Function: a Possible Novel Target for the…

    Principal investigator: Sylwester Tycjan Mosiołek

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 22, Panel: NZ7

  22. 372. unESKAPEable. Innovative antibiotics leads based on bifunctionalsed metallacarboranes to combat ESKAPE pathogens.

    Principal investigator: Jakub Cebula

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 22, Panel: NZ7

  23. 373. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b…

    Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 22, Panel: NZ7

  24. 374. Toxicity prediction for Novichoks: estimation of selected toxicological parameters for Novichoks as organophosphorus com…

    Principal investigator: dr Maciej Noga

    Instytut Ekspertyz Medycznych w Łodzi

    Call: PRELUDIUM 22, Panel: NZ7

  25. 375. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 22, Panel: NZ7

  26. 376. Modeling of the excipients effect on drug skin permeability

    Principal investigator: Laura Agnieszka Krumpholz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  27. 377. Chemosensors with molecularly imprinted polymers for determination of antiviral active drug substances in body fluids - …

    Principal investigator: dr Krzysztof Robert Noworyta

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: OPUS 25, Panel: NZ7

  28. 378. Design, Synthesis and Characterization of Functionalized 1,2,4-Trioxanes/Trioxepanes for Antimalarial and Anticancer Use

    Principal investigator: dr Mohit Kumar Tiwari

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATINA 7, Panel: NZ7

  29. 379. Blood plasma microRNA profile as a basis for detecting Alzheimer's disease and dementia risk in pre-symptomatic individu…

    Principal investigator: prof. Urszula Wojda

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 24, Panel: NZ7

  30. 380. The role of microvesicles in shaping exercise capacity in horses

    Principal investigator: dr Olga Danuta Witkowska-Piłaszewicz

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej

    Call: SONATA 18, Panel: NZ7

  31. 381. CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL …

    Principal investigator: prof. Jan Czesław Dobrowolski

    Narodowy Instytut Leków

    Call: OPUS 24, Panel: NZ7

  32. 382. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

    Call: OPUS 24, Panel: NZ7

  33. 383. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

    Call: SONATA 18, Panel: NZ7

  34. 384. Effect of the chronic treatment with lamotrigine on changes in expression of genes related to seizure processes in the s…

    Principal investigator: prof. Kinga Katarzyna Borowicz

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: PRELUDIUM BIS 4, Panel: NZ7

  35. 385. Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy i…

    Principal investigator: prof. Janusz Zbigniew Szemraj

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

    Call: PRELUDIUM BIS 4, Panel: NZ7

  36. 386. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high…

    Principal investigator: prof. Stefano Volinia

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

    Call: OPUS 24, Panel: NZ7

  37. 387. Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier in…

    Principal investigator: dr hab. Aneta Iwona Radziwon-Balicka

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: POLONEZ BIS 3, Panel: NZ7

  38. 388. Neuroprotective properties of β-cyclodextrin-1,2,4-triazole inclusion complexes

    Principal investigator: prof. Tomasz Sylwester Plech

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM BIS 4, Panel: NZ7

  39. 389. Targeted inhibition of hypusination pathway

    Principal investigator: dr Przemysław Marek Grudnik

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: OPUS 24, Panel: NZ7

  40. 390. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p…

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 4, Panel: NZ7

  41. 391. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

    Call: SONATA 18, Panel: NZ7

  42. 392. Assessment of the risk of tolerance, resistance and co-selection under various stress conditions in Escherichia coli.

    Principal investigator: dr Aleksandra Małgorzata Rapacka-Zdończyk

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: SONATA 18, Panel: NZ7

  43. 393. Customized DNA-based nanocarriers to boost heart healing

    Principal investigator: dr Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: M-ERA.NET 2022, Panel: NZ7

  44. 394. Step beyond classical lipophilicity - modeling of phospholipids affinity using immobilized artificial membranes chromato…

    Principal investigator: dr hab. Krzesimir Ciura

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: SONATA 18, Panel: NZ7

  45. 395. Extracellular vesicles as mediators of intercellular communication in an organism exposed to PET microplastics - multi-o…

    Principal investigator: Karol Mierzejewski

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

    Call: OPUS 24, Panel: NZ7

  46. 396. Exploring the unknown drug-like chemical space: new classes of sulfoximine derivatives and their biological activities.

    Principal investigator: prof. Maciej Filip Dawidowski

    Warszawski Uniwersytet Medyczny

    Call: OPUS 24, Panel: NZ7

  47. 397. Identification of key structural elements of immunomodulatory proteins - inhibitors of antigenic peptide transporter TAP…

    Principal investigator: dr Natalia Anna Karska

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 18, Panel: NZ7

  48. 398. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

    Principal investigator: prof. Rafał Artur Bartoszewski

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 24, Panel: NZ7

  49. 399. High-throughput PET imaging by decoding multi-photon signals on long axial field-of-view PET using physics-guided artifi…

    Principal investigator: prof. Ewa Łucja Stępień

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: OPUS 24 (LAP), Panel: NZ7

  50. 400. A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven dis…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 24 (LAP), Panel: NZ7

Graphic design and implementation: Jakub Piotrowski